Market Overview:
The global geriatric medicine market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the geriatric population, increase in awareness about geriatric medicines, and technological advancements are some of the major factors driving the growth of this market. Based on type, the analgesics segment is projected to lead the global geriatric medicine market during the forecast period. This segment is mainly driven by an increase in aging population and rising prevalence of chronic diseases such as cancer, arthritis, and neurological disorders among elderly people. In addition, increasing use of opioids for pain management is also contributing to the growth of this segment. Based on application, cardiovascular diseases are estimated to account for the largest share in 2018 followed by arthritis and neurological disorders respectively.
Product Definition:
Geriatric medicine is a medical specialty that focuses on the diagnosis, treatment and prevention of health problems specific to older adults. The importance of geriatric medicine lies in its ability to address the unique health needs of this population, which can often differ from those of younger adults. Geriatricians are experts in managing the complex physical, psychological and social issues that can affect seniors' health and wellbeing.
Analgesics:
Analgesics is a class of drug that reduces the pain sensation and provides temporary relief from acute pain. The analgesic drugs can be divided into two categories, namely non-opioid and opioid analgesics. Non-opioid analgesics include acetaminophen, ibuprofen, aspirin and others; while opioid Analgesics include codeine, morphine sulfate and fentanyl.
Antihypertensives:
Antihypertensives is a drug class that helps to lower blood pressure. The two types of antihypertensives are angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blockers (ARBs). Some of the common side effects include vision disturbances, skin rashes, diarrhea, nausea or vomiting, and headache.
Application Insights:
The global geriatric medicine market is segmented by application into cardiovascular, arthritis, neurology/psychiatry, cancer, osteoporosis and respiratory diseases. The cardiovascular segment dominated the overall market in terms of revenue share in 2017. Increasing prevalence of target diseases such as heart attack and stroke among geriatric population is expected to drive the demand for these medicines over the forecast period. For instance, according to a study published by National Health Statistics (NHS) in 2016 around 1 out of every 3 people aged 65 years or above suffered from some form of arthritis or joint disorder which accounted for about 19 million cases across America alone.
Moreover, increasing awareness about lifestyle modifications including regular exercise and healthy eating habits along with rising incidences associated with Cardiovascular Diseases (CVDs) are anticipated to further boost demand globally over the forecast period.
Regional Analysis:
Europe dominated the global market in 2017. The presence of a large geriatric population coupled with high healthcare expenditure and favorable reimbursement policies are some factors contributing to its growth. In addition, the growing prevalence of chronic diseases such as osteoporosis, arthritis, Parkinson’s disease is also expected to drive regional growth during the forecast period. Asia Pacific is expected to witness lucrative CAGR over the forecast period owing to increasing geriatric population and awareness about various available treatment options for them.
Moreover, government initiatives encouraging R&D activities on aging-related disorders will further fuel market development across this region Overlapping Therapeutic Indications (OTI) policy by Japan and U.S.
Growth Factors:
- Increasing geriatric population: The global geriatric population is expected to grow at a CAGR of 6.5% from 2016 to 2021, reaching 2.1 billion by 2021. This growth is primarily attributed to the increase in life expectancy and the growing awareness about health and fitness among the elderly population.
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, heart disease, stroke, and diabetes is high among the elderly population. This has led to an increased demand for geriatric medicine products and services worldwide.
- Technological advancements: There has been a significant advancement in technology used for diagnosing and treating chronic diseases in older adults in recent years. This has led to an increase in demand for geriatric medicine products and services globally..
Scope Of The Report
Report Attributes
Report Details
Report Title
Geriatric Medicine Market Research Report
By Type
Analgesics, Antihypertensives, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, Antidepressant
By Application
Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory
By Companies
GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca, Merck, Sanofi S.A.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Geriatric Medicine Market Report Segments:
The global Geriatric Medicine market is segmented on the basis of:
Types
Analgesics, Antihypertensives, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, Antidepressant
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Boehringer Ingelheim
- Novartis
- Bristol-Myers Squibb
- Pfizer
- Eli Lilly
- Abbott
- AstraZeneca
- Merck
- Sanofi S.A.
Highlights of The Geriatric Medicine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Analgesics
- Antihypertensives
- Statins
- Antidiabetics
- Proton Pump Inhibitor
- Anticoagulant
- Antipsychotic
- Antidepressant
- By Application:
- Cardiovascular
- Arthritis
- Neurological
- Cancer
- Osteoporosis
- Respiratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Geriatric Medicine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Geriatric medicine is a specialty of medicine that deals with the health and well-being of people age 65 and older. It includes diagnosing, treating, and managing conditions that commonly affect seniors, as well as providing preventive care.
Some of the key players operating in the geriatric medicine market are GSK, Boehringer Ingelheim, Novartis, Bristol-Myers Squibb, Pfizer, Eli Lilly, Abbott, AstraZeneca, Merck, Sanofi S.A..
The geriatric medicine market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Geriatric Medicine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Geriatric Medicine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Geriatric Medicine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Geriatric Medicine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Geriatric Medicine Market Size & Forecast, 2020-2028
4.5.1 Geriatric Medicine Market Size and Y-o-Y Growth
4.5.2 Geriatric Medicine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Analgesics
5.2.2 Antihypertensives
5.2.3 Statins
5.2.4 Antidiabetics
5.2.5 Proton Pump Inhibitor
5.2.6 Anticoagulant
5.2.7 Antipsychotic
5.2.8 Antidepressant
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cardiovascular
6.2.2 Arthritis
6.2.3 Neurological
6.2.4 Cancer
6.2.5 Osteoporosis
6.2.6 Respiratory
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Geriatric Medicine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Geriatric Medicine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Analgesics
9.6.2 Antihypertensives
9.6.3 Statins
9.6.4 Antidiabetics
9.6.5 Proton Pump Inhibitor
9.6.6 Anticoagulant
9.6.7 Antipsychotic
9.6.8 Antidepressant
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cardiovascular
9.10.2 Arthritis
9.10.3 Neurological
9.10.4 Cancer
9.10.5 Osteoporosis
9.10.6 Respiratory
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Analgesics
10.6.2 Antihypertensives
10.6.3 Statins
10.6.4 Antidiabetics
10.6.5 Proton Pump Inhibitor
10.6.6 Anticoagulant
10.6.7 Antipsychotic
10.6.8 Antidepressant
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cardiovascular
10.10.2 Arthritis
10.10.3 Neurological
10.10.4 Cancer
10.10.5 Osteoporosis
10.10.6 Respiratory
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Analgesics
11.6.2 Antihypertensives
11.6.3 Statins
11.6.4 Antidiabetics
11.6.5 Proton Pump Inhibitor
11.6.6 Anticoagulant
11.6.7 Antipsychotic
11.6.8 Antidepressant
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cardiovascular
11.10.2 Arthritis
11.10.3 Neurological
11.10.4 Cancer
11.10.5 Osteoporosis
11.10.6 Respiratory
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Analgesics
12.6.2 Antihypertensives
12.6.3 Statins
12.6.4 Antidiabetics
12.6.5 Proton Pump Inhibitor
12.6.6 Anticoagulant
12.6.7 Antipsychotic
12.6.8 Antidepressant
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cardiovascular
12.10.2 Arthritis
12.10.3 Neurological
12.10.4 Cancer
12.10.5 Osteoporosis
12.10.6 Respiratory
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Analgesics
13.6.2 Antihypertensives
13.6.3 Statins
13.6.4 Antidiabetics
13.6.5 Proton Pump Inhibitor
13.6.6 Anticoagulant
13.6.7 Antipsychotic
13.6.8 Antidepressant
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cardiovascular
13.10.2 Arthritis
13.10.3 Neurological
13.10.4 Cancer
13.10.5 Osteoporosis
13.10.6 Respiratory
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Geriatric Medicine Market: Competitive Dashboard
14.2 Global Geriatric Medicine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Boehringer Ingelheim
14.3.3 Novartis
14.3.4 Bristol-Myers Squibb
14.3.5 Pfizer
14.3.6 Eli Lilly
14.3.7 Abbott
14.3.8 AstraZeneca
14.3.9 Merck
14.3.10 Sanofi S.A.
